{'fraction_non_alphanumeric': 0.012861736334405145, 'fraction_numerical': 0.0, 'mean_word_length': 5.698924731182796, 'pattern_counts': {'":': 0, '<': 0, '<?xml version=': 0, '>': 0, 'https://': 0, 'lorem ipsum': 0, 'www.': 0, 'xml': 0}, 'pii_count': 0, 'substrings_counts': 0, 'word_list_counts': {'cursed_substrings.json': 0, 'profanity_word_list.json': 0, 'sexual_word_list.json': 0, 'zh_pornsignals.json': 0}}
Infections in neutropenic patients

Multidrug resistant pathogens such as enterococci, coliforms and pseudomonads are becoming endemic in many unit caring for neutropenic patients, probably becuse of the extensive use of prophylaxis and broad-spectrum therapy. Further studies of febrile episodes in neutropenia indicate that preventive and therapeutic regimens, such as quinolone prophylaxis and empirical monotherapy, can safely be tailored for specific risk groups to a greater extent than before. The past year has seen an increasing emphasis in the literature on cost control in the treatment of neutropenic patients.